Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Pending Challenges in Transradial Access

The recent SAFARI-STEMI study compared transradial and femoral access in patients with ST-segment elevation myocardial infarction, and no significant differences were found. These results have a sour taste for those in favor of transradial access, as they are convinced of its benefits and unwilling to go back to previous practices.

Desafíos pendientes con el acceso radial

This bitter taste is based on evidence rather than fanaticism; the SAFARI-STEMI should have conducted a more detailed analysis per treatment received, focusing on bleeding.

A good example comes from the RIVAL study: all major bleeding events in the radial arm were actually femoral complications. If this were also confirmed in SAFARI-STEMI, the importance of minimizing crossover would be clear.

Crossover from radial to femoral access occurred in 8.1% of patients in SAFARI-STEMI and in 7.6% in RIVAL. While this crossover rate is similar to what happens in daily clinical practice, its intent-to-treat analysis includes data that is hard to interpret.

Some measures can be taken to minimize crossover:

  • Failure in inserting the guidewire after a successful puncture is a fairly common issue. This may be due to tortuosity, puncture of a small side-branch, artery atherosclerosis or occlusion (in presence of a previous procedure). Solutions include inserting the guidewire using fluoroscopy and conducting a new puncture in a different place of the same artery—or in the contralateral artery.
  • Preventing spasms is another important issue. Using hydrophilic introducer sheaths, vasodilators, and small diameter catheters is helpful.
  • Careful insertion of catheters and guidewires is paramount. In case of sudden pain or resistance, the threshold to perform angiography should be very low. Some anatomical variants of the radial artery make the procedure difficult or impossible in about 15% of cases. Recognizing tortuosity, loops, or accessory radials helps to detect quick solutions.
  • Access can be moved from radial to contralateral or, in extreme circumstances, to transulnar. This was not specified in SAFARI-STEMI.

Read also: Intravascular Imaging: A Universal Approach for Angioplasty Optimization.


An important aspect in this particular group of patients—with ST-segment elevation myocardial infarction—is reperfusion time. Assuming that the time that an operator can take to deal with a challenging radial artery in these patients is much less than in stable patients is quite reasonable. Once again, we bring up the importance of a low threshold for radial angiography: the faster we know how is the radial artery we are dealing with, the faster the situation is solved—even if that means changing to a femoral artery.

Most femoral complications occur with operators who use transradial access almost exclusively (80-98%); consequently, being trained in both accesses is crucial.

Original Title: Residual Challenges in Radial Approach for Percutaneous Coronary Interventions.

Reference: Pierfrancesco Agostoni et al. JAMA Cardiol. 2020;5(12):1451-1452. doi:10.1001/jamacardio.2020.3730.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...